The Hindu Business Line : Sysmex in pact with Transasia for blood chemistry analysers

SYSMEX Corporation, a Japanese diagnostics major, has finalised an agreement with Mumbai's Transasia Bio-medicals Ltd to source a high throughput clinical chemistry system.

According to the agreement between the two companies, Chemix 800, a blood chemistry analyser developed by Transasia, will be marketed worldwide by Sysmex.

The product would be marketed globally under the `Sysmex Transasia' brand name, said Mr Suresh Vazirani, Chairman and Managing Director of Transasia.

The agreement would be valid for six years and in this period, the total sales of analysers is expected to be worth about Rs 100 crore, he added.

Transasia has invested over Rs 10 crore for the development of Chemix 800, which has a processing speed of 600 tests per hour.

According to Mr Vazirani, the global market for analysers and its reagents is over Rs 25,000 crore annually. The company also expects to launch a sensitive tuberculosis kit in about a year.

Sysmex Corporation has a turnover of over Rs 3,000 crore and operates in the fields of hematology, coagulation and urine analysis systems.

The estimated Rs 100-crore Transasia is a diagnostics systems company that produces solutions for quality blood analysis, analysers and reagents.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Snow World develops indoor Go Karting track

Neuland allots share warrants

BHEL bags Rs 1,198-cr order

Cargill to demerge fertiliser business into Mosaic India

S&N to pick up 17.5% stake in UB — To make open offer for another 20 pc at Rs 575 a share

CavinKare to begin operations in Bangladesh, Indonesia soon

Sysmex in pact with Transasia for blood chemistry analysers

Cadila to focus on cardiovascular, gastroenteritis segments